Back to Search Start Over

Free-viewing gaze patterns reveal a mood-congruency bias in MDD during an affective fMRI/eye-tracking task.

Authors :
Sun, Rui
Fietz, Julia
Erhart, Mira
Poehlchen, Dorothee
Henco, Lara
Brückl, Tanja M.
Binder, Elisabeth B.
Erhardt, Angelika
Lucae, Susanne
Grandi, Norma C.
Namendorf, Tamara
Elbau, Immanuel
Leuchs, Laura
Brem, Anna Katharine
Schilbach, Leonhard
Ilić-Ćoćić, Sanja
Ziebula, Julius
von Mücke-Heim, Iven-Alex
Kim, Yeho
Pape, Julius
Source :
European Archives of Psychiatry & Clinical Neuroscience; Apr2024, Vol. 274 Issue 3, p559-571, 13p
Publication Year :
2024

Abstract

Major depressive disorder (MDD) has been related to abnormal amygdala activity during emotional face processing. However, a recent large-scale study (n = 28,638) found no such correlation, which is probably due to the low precision of fMRI measurements. To address this issue, we used simultaneous fMRI and eye-tracking measurements during a commonly employed emotional face recognition task. Eye-tracking provide high-precision data, which can be used to enrich and potentially stabilize fMRI readouts. With the behavioral response, we additionally divided the active task period into a task-related and a free-viewing phase to explore the gaze patterns of MDD patients and healthy controls (HC) and compare their respective neural correlates. Our analysis showed that a mood-congruency attentional bias could be detected in MDD compared to healthy controls during the free-viewing phase but without parallel amygdala disruption. Moreover, the neural correlates of gaze patterns reflected more prefrontal fMRI activity in the free-viewing than the task-related phase. Taken together, spontaneous emotional processing in free viewing might lead to a more pronounced mood-congruency bias in MDD, which indicates that combined fMRI with eye-tracking measurement could be beneficial for our understanding of the underlying psychopathology of MDD in different emotional processing phases. Trial Registration: The BeCOME study is registered on ClinicalTrials (gov: NCT03984084) by the Max Planck Institute of Psychiatry in Munich, Germany. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09401334
Volume :
274
Issue :
3
Database :
Complementary Index
Journal :
European Archives of Psychiatry & Clinical Neuroscience
Publication Type :
Academic Journal
Accession number :
177350749
Full Text :
https://doi.org/10.1007/s00406-023-01608-8